Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.695 USD | +10.06% | +1.56% | +6.21% |
04-30 | Leerink Partners Starts Lexicon Pharmaceuticals With Outperform Rating, $5 Price Target | MT |
04-29 | Lexicon Pharmaceuticals' Chief Executive Lonnel Coats to Retire | MT |
Official Publications
No official publication found
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Official Publications